Primary Menu
AUCKLAND, NEW ZEALAND - SEPTEMBER 10: A measles vaccine is prepared on September 10, 2019 in Auckland, New Zealand. The New Zealand health ministry confirmed 1,051 people have were affected between 1 January and 5 September, 2019. The bulk of cases have been in Auckland in Auckland as health authorities and the Prime Minister implore people to ensure they are vaccinated against the disease. (Photo by Fiona Goodall/Getty Images)

Pfizer says its COVID-19 vaccine is 100 percent effective in teens between the ages of 12 and 15, according to late-stage trial data.

The company says none of the teens given the vaccine during the trial became infected with COVID-19, while 18 teens in the placebo group were infected.

Pfizer will now seek approval from the FDA to offer the vaccine to teenage children, possibly in time for the new school year in the fall.

The vaccine is given in two doses three weeks apart and is already cleared for emergency use in people ages 16 and up, according to NBC News.

Last week, the company launched another vaccine trial test for children ages 6 months to 11 years.

Katherine Viloria is Beasley Media Group's Fort Myers Digital Content Manager. She loves to write, snap photos, and watch Grey's Anatomy. Connect with her on Instagram @alittlethisalittlekat